Network Immunology
Description
pulled from site's meta descriptionNetwork Immunology is a biotech company based in Vancouver BC, Canada. The company focuses on HIV vaccine development, organ transplantation facilitation technologies, treatments and preventions for autoimmune diseases, and other biotechnologies emerging from a Network Theory of the immune system as pioneered by Dr. Niels Jerne and Dr. Geoffrey W. Hoffmann. Network Immunology owns Intellectual Property rights to three industry-changing technologies, the scope of which are very large. Its primary focus is a preventive HIV vaccine. The company now has multiple lines of supporting evidence for this HIV vaccine. The company's second technology is a treatment that makes organ transplants safe and easy, even in the absence of a genetically matching donor. The company has strong supporting evidence at this stage and is raising capital for further development of its technologies. The achievement of upcoming milestones will put Network Immunology in the forefront of the biotechnology industry and ultimately help to enhance and prolong the lives of people worldwide. This Canadian company is currently offering investment opportunities. If one is interested, please contact us for further information about the opportunity.
This is an automatically generated AboutUs page for networkimmunologyinc.com. Click the "Edit" button at the top of the page to make changes. Please read our Getting Started page if you need any help.
- AboutUs AutoGen
- hiv
- vaccine
- hiv vaccine
- hiv vaccine development
- aids
- aids vaccine
- aids vaccine development
- biotech
- biotech company
- biotech companies
- biotechs
- biotechnology companies
- biotechnology company
- biotech vancouver
- biotech companies vancouver
- biotech investment
- biotech investments
- biotech stocks
- canadian biotech stocks
- vaccine company
- vaccine companies
- organ transplant
- organ transplant therapy
- organ transplant therapies
- organ transplant therapeutics
- hoffivac
- hoffitran
- biotechnologies
- biotechnologies canada
- biotechnology canada
- canadian biotechnology
- canadian biotechnologies
- canadian investment opportunities
- biotech investment opportunity
- investments in canada
- antibodies
- antibody
- idiotypic network theory